Navigation Links
Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
Date:9/10/2008

od and urine samples taken after this period served as a baseline standard to help determine the extent of participant compliance with the study guidelines.)

As a quality control for the rooibos, a large quantity of rooibos of the same batch was obtained from Rooibos Ltd., the major rooibos producer and supplier in Clanwilliam, South Africa. To ensure consistent quality the researchers took random samples of the rooibos from this one large batch and analyzed them for key chemical compounds (e.g. flavonols) and antioxidant capacity.

The clinical trial design and some of its initial results were announced in a presentation by Dr. Marnewick at the World Tea Expo in Las Vegas, Nevada in May. The trial paper will be submitted to a medical journal for publication after all the statistical data has been fully analyzed, probably by the end of this year.

"Despite its long history of traditional use in South Africa and growing popularity around the world as a tasty and healthful beverage, this is the first time that rooibos has been subjected to a tightly controlled human clinical trial to determine its potential benefit in reducing cardiovascular disease factors," said Mark Blumenthal, founder and executive director of the American Botanical Council, the leading nonprofit organization dealing with herbs, medicinal teas, and related plant-based ingredients.

"With cardiovascular disease being the biggest killer of people in North America and elsewhere in the world, this study's preliminary positive results may help increase the relevance of rooibos as a beneficial beverage for consumers and healthcare providers seeking safe, low-cost ways to reduce cardiovascular disease risk," he added.

Members of the tea industry welcomed the preliminary research findings. "We are extremely excited about the preliminary results of this clinical trial," says Hugh Lamond from Herbal Teas International of Anaheim, California, the largest distributor of rooibos
'/>"/>

SOURCE American Botanical Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
2. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
3. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
4. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
7. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
8. Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
9. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
10. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
11. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 15, 2014  Stephen Squires, CEO and founder of ... Corp (OTCQB:QTMM), will be speaking at the launch ... on December 16th, 2014. The RCQM launch continues Rice ... attracting top faculty and students and by inviting the ... "We have a long association with ...
(Date:12/15/2014)... Government of Ghana has endorsed a project ... Terumo BCT to respond to the emerging Ebola crisis within ... system capacity to the citizens of Ghana . ... and Resilience Initiative (GERRI) is a multi-agency effort designed to: ... arrival of the Ebola epidemic , Provide new blood product ...
(Date:12/14/2014)... 2014  ChartSpan, a consumer platform for patients managing ... iPad medical app in the United States ... ChartSpan is an iPhone and iPad ... and send electronic healthcare records. The product was built ... of waiting for the healthcare system to deliver on ...
Breaking Medicine Technology:Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3
... , , , , ... and development company, announced today that it has closed a $6.5M Series ... technology for CM-AT for autism. Phase III clinical trials are about to ... "The Series A funding will allow us to complete our clinical trials ...
... , LOS ANGELES, Aug. 7 A new ... any drug and sealed to the outer surface (episclera) of the ... of medicines for retinal and vitreous diseases, according to a new ... in The Vision Center at Children,s Hospital Los Angeles. Dr. Murphree ...
Cached Medicine Technology:Curemark Closes Series A Financing 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 3Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... been successfully treated for their disease face the ... testicular) tissue is transplanted back into their bodies ... university hospitals in Israel. , Writing in Europes ... 22 April), the researchers say that hundreds of ...
... ,biological mechanism, that leads to adverse reactions identified, officials ... heparin products have now been found in at least ... ongoing surveillance measures to ensure the safety of the ... addition, officials said contaminated lots of the blood thinner ...
... stories of suffering from trauma victims causes serious psychological ... suggests. , In a study appearing in the May ... Investigator Joseph Boscarino, PhD, MPH and his co-researchers examined ... New York City social workers following the Sept. 11 ...
... highlights:, -- Record quarterly net sales of $668.2 million, up 13.4% year over year and ... share, up 12.5% over the same period last year, -- Record quarterly Catalysts segment income of $51.7 million resulting ... ... First Quarter ...
... OMCL ), a leading provider of system solutions ... quarter ended,March 31, 2008., GAAP results: Revenues for ... million or 7.2% from the fourth quarter of 2007 ... of 2007., First quarter 2008 net income as ...
... ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced ... 30, 2008, after the U.S. markets,close. ISTA will host ... results at 4:30 p.m. Eastern Time on April 30., ... Canadian participants may,dial 866-362-5158; international participants may dial 617-597-5397. ...
Cached Medicine News:Health News:Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation 2Health News:Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation 3Health News:FDA: Contaminated Heparin Found in 10 Countries 2Health News:FDA: Contaminated Heparin Found in 10 Countries 3Health News:FDA: Contaminated Heparin Found in 10 Countries 4Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 2Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 3Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 4Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 5Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 6Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 7Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 8Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 9Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 10Health News:Omnicell Announces First Quarter 2008 Results 2Health News:Omnicell Announces First Quarter 2008 Results 3Health News:Omnicell Announces First Quarter 2008 Results 4Health News:Omnicell Announces First Quarter 2008 Results 5Health News:Omnicell Announces First Quarter 2008 Results 6Health News:Omnicell Announces First Quarter 2008 Results 7Health News:Omnicell Announces First Quarter 2008 Results 8Health News:Omnicell Announces First Quarter 2008 Results 9Health News:Omnicell Announces First Quarter 2008 Results 10Health News:Omnicell Announces First Quarter 2008 Results 11
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... Tendril SDX model 1688 and model 1488 ... extendable/retractable pacing leads, offering the unsurpassed handling ... Jude Medical's line of active-fixation leads. Implantable ... body diameter of the Tendril SDX lead ...
... battery-backed up, microprocessor based, quality instrument that monitors ... and displays a chart on its large panel ... or zoomed into and out of, so that ... months can be seen at one time. ...
... Aegis CheckPoint is an automated, wireless, ... and alert system for refrigerator, freezer, ... chart recorders, data loggers and manual ... on an existing PC and comes ...
Medicine Products: